Renflexis Copay Assistance: Accessible Treatment Options for Canadians with RA, IBD, and Inflammatory Arthritis

As many as one in every 100 Canadian adults suffers from rheumatoid arthritis (RA), making it a significant public health concern. Additionally, inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis affect over 229,000 Canadians, while inflammatory arthritis affects individuals at every stage of life. With the burden of these conditions being substantial, it is essential to ensure that patients have access to effective treatment options.

Recently, Merck Canada announced that the province of British Columbia will now reimburse RENFLEXIS™ (infliximab for injection) under its public drug plan effective August 21, 2018. This development brings relief to patients with Crohn's disease and ulcerative colitis, as well as those affected by fistulising Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults.

RENFLEXIS™ is approved for the treatment of these conditions in adult and pediatric patients. The addition of RENFLEXIS™ to British Columbia's drug formulary offers more affordable treatment options for patients impacted by these diseases. According to Manon Lafontaine, Vice-President, Patient Access, Merck Canada, 'We are pleased to see the government of British Columbia add Renflexis to its formulary, which offers effective and more affordable treatment options for patients impacted by these diseases.'

The inclusion of RENFLEXIS™ in the British Columbia drug formulary is a significant step towards improving patient access to care. Merck Canada remains committed to working with provinces and territories throughout Canada to ensure that all patients have access to the care they need.

In conclusion, the addition of RENFLEXIS™ to British Columbia's public drug plan marks an important milestone in the fight against RA, IBD, and inflammatory arthritis. With more affordable treatment options available, patients can receive the care they need to manage their conditions and improve their quality of life.

Renflexis copay assistance